Insight Molecular Diagnostics Inc.(IMDX:US)

Market Cap$97.18M

Key Metrics

Price$3.01

Revenue (TTM)$1.95M

Holders Revenue (TTM)$0

Gross Profit (TTM)$1M

Earnings (TTM)-$47.84M

EBITDA (TTM)-$31.59M

Op. Margin (TTM)-1.79K%

Dividend Yield-

Holders Yield-

Cash on hand$28.2M

Total Assets$40.43M

Net Assets-$10.69M

Total Debt$3.07M

Insight Molecular Diagnostics Inc.(IMDX:US)

Market Cap$97.18M

Price history

Key Metrics

Price$3.01

Revenue (TTM)$1.95M

Holders Revenue (TTM)$0

Gross Profit (TTM)$1M

Earnings (TTM)-$47.84M

EBITDA (TTM)-$31.59M

Op. Margin (TTM)-1.79K%

Dividend Yield-

Holders Yield-

Cash on hand$28.2M

Total Assets$40.43M

Net Assets-$10.69M

Total Debt$3.07M

Financials

NameMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
Revenue
$32K$1.14M$260K$518K-----
Cost of Revenue
$17K$643K$121K$168K-----
Gross Profit
$15K$496K$139K$350K$1.33M$595K$50K$50K$45K
$10.09M$10.21M$7.58M$7.11M-----
Research and Development$4.95M$5.83M$3.88M$3.28M-----
Selling, General, and Administrative$5.14M$4.38M$3.7M$3.83M-----
Other Operating Expenses---------
Operating Income
-$10.33M-$9.95M-$7.67M-$6.97M-----
$6.04M-$13.01M-$3.18M-$2.77M-----
Non-Operating Interest Income---------
Non-Operating Interest Expense$23K$26K$29K$25K-----
Other Income/Expense$6.06M-$12.98M-$3.16M-$2.75M-----
Income Before Tax
-$4.29M-$22.96M-$10.85M-$9.74M-----
Income Tax
$0-$0$0-----
Net Income
-$4.29M-$22.96M-$10.85M-$9.74M-----
Minority Interests
---------
Preferred Stock Dividends
--$0$0-----
Net Income to Common
-$4.29M-$22.96M-$10.85M-$9.74M-----
Shares Outstanding (Basic)
34.52M32.07M32.03M32.02M25.69M17.38M13.71M12.87M-
Shares Outstanding (Diluted)
34.52M32.07M32.03M32.02M25.69M17.38M13.71M12.87M-
EPS (Basic)
-$0.12-$0.72-$0.34-$0.30-$0.26-$1.93-$0.98-$0.36-
EPS (Diluted)
-$0.12-$0.72-$0.34-$0.30-$0.26-$1.93-$0.98-$0.36-
EBIT
-$4.27M-$22.93M-$10.83M-$9.72M-----
EBITDA
-$9.55M-$8.88M-$6.86M-$6.29M-----